The affidavit filed by activist Aruna Rodrigues, who had sought a complete moratorium on field trial of GMO, said the final report and documents by the expert committee (TEC) recommended no field trials till regulatory gaps are addressed as there have been serious shortcomings in the GMO regulatory process.
The affidavit filed through advocate Prashant Bhushan said the TEC in their 'covering letter' to their final report indicated that Paroda was not present to sign it on June 30, 2013, nor did he give a dissenting note.
The anti-GMO activist said the affidavit was being filed to provide evidence that "the apex court's mandate of independence as a regulatory objective and specifically in the context of its TEC has been breached" with Paroda's induction.
The affidavit claimed that there is evidence of both institutional and personal conflict of interest that enmesh Paroda.
"Paroda ought to have recused himself for the same reason, especially after his conflict of interest became a public issue," the affidavit said.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
